Volume 9 Supplement 1

4th International Conference of cGMP Generators, Effectors and Therapeutic Implications

Open Access

Quantitation of cyclic dinucleotides by reversed-phase LC-MS/MS

BMC Pharmacology20099(Suppl 1):P65

https://doi.org/10.1186/1471-2210-9-S1-P65

Published: 11 August 2009

Cyclic nucleotides function as second messengers in all kingdoms of life. Recently, cyclic dinucleotides (c-di-NMPs) have been identified as bacterial signaling molecules. Cyclic diguanosine monophosphate (c-di-GMP) plays a major role in the modulation of bacterial surface components. Synthesis and degradation of c-di-GMP is controlled by so-called GGDEF (diguanylate cyclase activity) and EAL (phosphodiesterase activity) domains, respectively. These domains influence the sessility and motility of bacteria via regulation of biosynthesis of exopolysaccharides (e.g. cellulose) and fimbriae. Thus, the c-di-GMP level affects the formation of biofilms that represent the predominant form in which bacteria exist in the natural environment. The progress and persistence of many infectious diseases is based on biofilm formation by bacterial pathogens.

Hence, there is a great need for the establishment of a robust and sensitive quantitation method for cyclic dinucleotides. Recently, a matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF) method for the detection of c-di-GMP has been reported [1]. However, quantitation of low molecular weight molecules by MALDI-TOF is rather problematic and the described method requires a tedious separate chromatographic work-up step prior to the sample preparation for the final MALDI-TOF analysis. We have established a much more simple and sensitive quantitation method for c-di-NMPs using a reversed-phase liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS) system with xanthosine 3',5'-cyclic monophosphate (cXMP) as internal standard (LOD = 4 ng/mL, see Figure 1). Cyclic diadenosine monophosphate (c-di-AMP) would be the most suitable internal standard in terms of close structural relation and comparable chromatographic behavior. However, c-di-AMP may also be present in bacteria and thus might interfere with the determination of c-di-GMP levels.
Figure 1

Calibration curve for c-di-GMP obtained by LC-MS/MS with a reversed-phase column and cXMP as internal standard.

We will apply the established method for the quantitation of c-di-NMPs in various Pseudomonas aeruginosa strains and aim at determining the enzymatic activity of diguanylate cyclase.

Declarations

Acknowledgements

The authors thank Dr. H.-G. Genieser and Dr. F. Schwede (BioLog, Bremen, Germany) for providing cyclic dinucleotide standards.

Authors’ Affiliations

(1)
Institute of Pharmacology, Hannover Medical School

References

  1. Simm R, Morr M, Remminghorst U, Andersson M, Römling U: Quantitative determination of cyclic diguanosine monophosphate concentrations in nucleotide extracts of bacteria by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Anal Biochem. 2009, 386: 53-58. 10.1016/j.ab.2008.12.013.View ArticlePubMedGoogle Scholar

Copyright

© Spangler et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement